Close Menu

NEW YORK (GenomeWeb) – Cepheid reported after the close of the market Thursday that its third quarter revenues increased 25 percent year over year.

The Sunnyvale, California-based molecular diagnostics firm, which signed a deal in September to be acquired by Danaher for around $4 billion, released its earnings through a quarterly report filed with the US Securities and Exchange Commission.

To read the full story....

...and receive Daily News bulletins.

Already have a 360Dx or GenomeWeb account?
Login Now.

Don't have a 360Dx or GenomeWeb account?
Register for Free.

Jun
04
Sponsored by
Ovation

This webinar will discuss the current status of COVID-19 testing, treatment and other aspects of the current pandemic as they relate to getting this outbreak under control.  

Jul
15
Sponsored by
LGC SeraCare Life Sciences

Cancer immunotherapy is an exciting new advance for the successful treatment of many forms of metastatic cancer.